Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mapi Pharma Receives Additional Claims for Its U.S. Patent for Glatiramer Acetate Depot for the Treatment of Multiple Sclerosis
Novel Immune Regulator Shows Promise as MS Therapy in Clinical Trials
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Galectin-1 for neuroprotection?
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Rituximab: Don't Count It Out as MS Treatment
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Clinical overview of the seizure risk of dalfampridine.
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Development of the Brief Inventory of Perceived Stress.
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis.
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.

Pages